Kay Dickersin | Academic Influence

Kay Dickersin's AcademicInfluence.com Rankings

Kay Dickersin

Medical

#1417

World Rank

#1754

Historical Rank

#378

USA Rank

Epidemiology

#263

World Rank

#280

Historical Rank

#53

USA Rank

medical Degrees

Download Badge

Medical

Kay Dickersin's Degrees

PhD Epidemiology Johns Hopkins University
Masters Public Health University of North Carolina at Chapel Hill
Bachelors Biology University of North Carolina at Chapel Hill

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Kay Dickersin Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Kay Dickersin is an academic who trained first in cell biology and subsequently epidemiology. She went on to a career studying factors that influence research integrity, in particular publication bias and outcome reporting bias. She is retired Professor Emerita in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health where she was Director of the Center for Clinical Trials and Evidence Synthesis there. She was also Director of the US Cochrane Center and the US Satellite of the Cochrane Eyes and Vision Group within the Cochrane Collaboration. Dickersin received multiple awards for her research.

(See a Problem?)

Kay Dickersin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations (2015) (3720)
SPIRIT 2013 statement: defining standard protocol items for clinical trials. (2013) (3679)
Osteoporosis prevention, diagnosis, and therapy. (2001) (3506)
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials (2013) (3035)
Systematic Reviews: Identifying relevant studies for systematic reviews (1994) (1726)
The prevention and treatment of missing data in clinical trials. (2012) (1495)
The existence of publication bias and risk factors for its occurrence. (1990) (1358)
Osteoporosis prevention, diagnosis, and therapy. (2000) (1251)
Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. (1992) (861)
Publication bias in clinical trials due to statistical significance or direction of trial results. (2009) (782)
Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. (2002) (749)
SPIRIT 2013 Statement: defining standard protocol items for clinical trials. (2015) (688)
Increasing value and reducing waste: addressing inaccessible research (2014) (667)
Publication bias and clinical trials. (1987) (645)
Meta-analysis: state-of-the-science. (1992) (502)
Full publication of results initially presented in abstracts. A meta-analysis. (1994) (433)
Publication Bias: The Problem That Won't Go Away (1993) (380)
Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group. (1995) (376)
Getting to grips with Archie Cochrane's agenda. (1992) (374)
Publication bias in editorial decision making. (2002) (336)
How important is publication bias? A synthesis of available data. (1997) (329)
Network meta-analysis-highly attractive but more methodological research is needed (2011) (314)
Outcome reporting in industry-sponsored trials of gabapentin for off-label use. (2009) (306)
Publication Bias: Recognizing the Problem, Understanding Its Origins and Scope, and Preventing Harm (2006) (301)
The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. (2002) (266)
NIH clinical trials and publication bias. (1993) (264)
Registering clinical trials. (2003) (262)
Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. (1996) (244)
Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1) (2005) (214)
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. (2014) (209)
A cohort study of summary reports of controlled trials. (1990) (207)
SPIRIT 2013: new guidance for content of clinical trial protocols (2013) (206)
Effectiveness of the 40 adolescent AIDS-risk reduction interventions: a quantitative review. (1997) (200)
Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis. (2016) (195)
Development of the Cochrane Collaboration’s Central Register of Controlled Clinical Trials (2002) (183)
Restoring invisible and abandoned trials: a call for people to publish the findings (2013) (180)
Problems and Limitations in Conducting Systematic Reviews (2008) (170)
Perusing the literature: comparison of MEDLINE searching with a perinatal trials database. (1985) (162)
Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis. (1998) (159)
The Oxford Database of Perinatal Trials: developing a register of published reports of controlled trials. (1986) (137)
ACCF/AHA Clinical Practice Guideline Methodology Summit Report: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2013) (136)
Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians and pediatricians. (1989) (126)
Systematic reviews in epidemiology: why are we so far behind? (2002) (122)
Hormone replacement therapy, cancer, controversies, and women’s health: historical, epidemiological, biological, clinical, and advocacy perspectives (2005) (118)
The Cochrane Collaboration: evaluation of health care and services using systematic reviews of the results of randomized controlled trials. (1998) (113)
Impact of consumer health informatics applications. (2009) (113)
Financial and quality-of-life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment. (2009) (113)
Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma (1998) (110)
Evidence based medicine: increasing, not dictating, choice (2007) (109)
Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis. (2011) (107)
Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study (2017) (106)
Experience Corps: A dual trial to promote the health of older adults and children's academic success (2013) (105)
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) (103)
Defining race/ethnicity and explaining difference in research studies on lung function (2012) (103)
Publication bias against negative results from clinical trials: three of the seven deadly sins (2007) (101)
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement. (2021) (100)
The evolution of trial registries and their use to assess the clinical trial enterprise. (2012) (98)
Ischemic Optic Neuropathy Decompression Trial: twenty-four-month update. (2000) (98)
Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO (2011) (96)
Hysterectomy Compared With Endometrial Ablation for Dysfunctional Uterine Bleeding: A Randomized Controlled Trial (2007) (91)
WHO facilitates international collaboration in setting standards for clinical trial registration (2005) (91)
Shaping the future of biomarker research in breast cancer to ensure clinical relevance (2007) (90)
Is there a sex bias in choosing editors? Epidemiology journals as an example. (1998) (85)
Differences in Reporting of Analyses in Internal Company Documents Versus Published Trial Reports: Comparisons in Industry-Sponsored Trials in Off-Label Uses of Gabapentin (2013) (84)
Innovations in Data Collection, Management, and Archiving for Systematic Reviews (2015) (79)
Outcomes in Cochrane Systematic Reviews Addressing Four Common Eye Conditions: An Evaluation of Completeness and Comparability (2014) (77)
Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis. (2017) (77)
Identifying relevant studies for systematic reviews. (1994) (74)
Declaración SPIRIT 2013: definición de los elementos estándares del protocolo de un ensayo clínico* (2015) (72)
The ischemic optic neuropathy decompression trial (IONDT): design and methods. (1998) (72)
Design, Analysis, and Reporting of Crossover Trials for Inclusion in a Meta-Analysis (2015) (69)
Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy. (2017) (66)
The design and conduct of clinical trials to limit missing data (2012) (64)
Report from the panel on the Case for Registers of Clinical Trials at the Eighth Annual Meeting of the Society for Clinical Trials. (1988) (59)
Compliance of clinical trial registries with the World Health Organization minimum data set: a survey (2009) (59)
Consumer involvement in systematic reviews of comparative effectiveness research (2013) (59)
Standards should be applied in the prevention and handling of missing data for patient-centered outcomes research: a systematic review and expert consensus. (2014) (59)
Selective exposure reporting and Medline indexing limited the search sensitivity for observational studies of the adverse effects of oral contraceptives. (2005) (59)
What Comparative Effectiveness Research Is Needed? A Framework for Using Guidelines and Systematic Reviews to Identify Evidence Gaps and Research Priorities (2012) (59)
Quantitative impact of including consumers in the scientific review of breast cancer research proposals. (2002) (58)
Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials (2021) (58)
Structure and composition of the cytoskeleton of nucleated erythrocytes I. The presence of microtubule-associated protein 2 in the marginal band (1980) (57)
Practical guidance for using multiple data sources in systematic reviews and meta‐analyses (with examples from the MUDS study) (2017) (54)
Consumer health informatics: results of a systematic evidence review and evidence based recommendations (2011) (52)
Newspaper Reporting of Screening Mammography (2002) (52)
Metabias: A Challenge for Comparative Effectiveness Research (2011) (51)
Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. (2012) (49)
Association between time interval to publication and statistical significance. (2002) (47)
The Emergence of Systematic Review in Toxicology (2016) (45)
Keeping posted Why register clinical trials?-Revisited (1992) (42)
Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigation (2012) (42)
Comparative effectiveness research: Challenges for medical journals (2010) (41)
Identification of meta-analyses. The need for standard terminology. (1990) (41)
Development and implementation of a science training course for breast cancer activists: Project LEAD (leadership, education and advocacy development) (2001) (39)
Problems with indexing and citation of articles with group authorship. (2002) (39)
Oncologists’ Confidence in Knowledge of Fertility Issues for Young Women with Cancer (2012) (37)
Network Meta-analysis for Clinical Practice Guidelines: A Case Study on First-Line Medical Therapies for Primary Open-Angle Glaucoma (2016) (35)
Publication bias in clinical trials (2007) (34)
Flawed inferences about screening mammography's benefit based on observational data. (2009) (32)
Understanding why evidence from randomised clinical trials may not be retrieved from Medline: comparison of indexed and non-indexed records (2012) (32)
Biased under-reporting of research reflects biased under-submission more than biased editorial rejection (2013) (32)
Research Questions and Outcomes Prioritized by Patients With Dry Eye (2018) (32)
Dependability of results in conference abstracts of randomized controlled trials in ophthalmology and author financial conflicts of interest as a factor associated with full publication (2016) (32)
Agreement of data in abstracts compared to full publications (1998) (31)
To Reform U.S. Health Care, Start with Systematic Reviews (2010) (31)
Setting priorities for comparative effectiveness research: a case study using primary open-angle glaucoma. (2010) (30)
Visual fields at follow-up in the Ischemic Optic Neuropathy Decompression Trial: evaluation of change in pattern defect and severity over time. (2008) (30)
Misunderstandings, misperceptions, and mistakes (2007) (30)
What do the JAMA editors say when they discuss manuscripts that they are considering for publication? Developing a schema for classifying the content of editorial discussion (2007) (28)
Comparison of information obtained by operative note abstraction with that recorded on a standardized data collection form. (2003) (28)
Publication of clinical trials: accountability and accessibility (2004) (27)
Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events. (2019) (27)
The Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding: summary of an Agency for Health Research and Quality-sponsored randomized trial of endometrial ablation versus hysterectomy for women with heavy menstrual bleeding (2011) (26)
Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB): design and methods. (2003) (25)
Are manufacturers sharing data as promised? (2015) (25)
Interventions for acute internal hordeolum. (2013) (25)
Why register clinical trials?--Revisited. (1992) (25)
Citation of previous meta-analyses on the same topic: a clue to perpetuation of incorrect methods? (2013) (24)
Setting Priorities for Comparative Effectiveness Research on Management of Primary Angle Closure: A Survey of Asia-Pacific Clinicians (2015) (24)
Engaging Stakeholders to Inform Clinical Practice Guidelines That Address Multiple Chronic Conditions (2017) (24)
Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events (2019) (23)
Comparison of Clinical Trial and Systematic Review Outcomes for the 4 Most Prevalent Eye Diseases (2017) (22)
Comparative effectiveness research: challenges for medical journals. (2010) (22)
ClinicalTrials.gov registration can supplement information in abstracts for systematic reviews: a comparison study (2013) (20)
Gender and Editorial Authorship in High-Impact Epidemiology Journals (2019) (20)
Surgery for nonarteritic anterior ischemic optic neuropathy. (2000) (20)
Clinical trials and systematic reviews addressing similar interventions for the same condition do not consider similar outcomes to be important: a case study in HIV/AIDS. (2017) (20)
[Table, Finding Grey Literature Evidence and Assessing for Outcome and Analysis Reporting Biases When Comparing Medical Interventions: AHRQ and the Effective Health Care Program]. (2013) (19)
Breast screening in women aged 40–49 years: what next? (1999) (19)
Can We Depend on Investigators to Identify and Register Randomized Controlled Trials? (2012) (19)
Interventions for Age-Related Macular Degeneration: Are Practice Guidelines Based on Systematic Reviews? (2016) (19)
Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events. (2019) (17)
Outcome choice and definition in systematic reviews leads to few eligible studies included in meta-analyses: a case study (2020) (17)
Evaluation of Systematic Reviews of Interventions for Retina and Vitreous Conditions. (2019) (17)
Surgical quality assurance in the Ischemic Optic Neuropathy Decompression Trial (IONDT). (2003) (16)
Standards for design and measurement would make clinical research reproducible and usable (2018) (16)
Caveat emptor: the combined effects of multiplicity and selective reporting (2018) (15)
Reporting Weaknesses in Conference Abstracts of Diagnostic Accuracy Studies in Ophthalmology. (2015) (15)
Non-surgical interventions for acute internal hordeolum. (2017) (15)
Design considerations of a randomized controlled trial of sedation level during hip fracture repair surgery: a strategy to reduce the incidence of postoperative delirium in elderly patients (2017) (14)
Social network analysis identified central outcomes for core outcome sets using systematic reviews of HIV/AIDS. (2016) (14)
Reported estimates of diagnostic accuracy in ophthalmology conference abstracts were not associated with full-text publication. (2016) (14)
A randomized trial provided new evidence on the accuracy and efficiency of traditional vs electronically annotated abstraction approaches in systematic reviews. (2019) (13)
Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol for a systematic review (2015) (13)
Who Has Used Internal Company Documents for Biomedical and Public Health Research and Where Did They Find Them? (2014) (13)
Reliability of the Evidence Addressing Treatment of Corneal Diseases: A Summary of Systematic Reviews. (2019) (13)
Setting Priorities for Diabetic Retinopathy Clinical Research and Identifying Evidence Gaps. (2017) (12)
Gaps in Current Knowledge and Priorities for Future Research in Dry Eye (2017) (12)
Evaluating Data Abstraction Assistant, a novel software application for data abstraction during systematic reviews: protocol for a randomized controlled trial (2016) (11)
Using ClinicalTrials.gov to Supplement Information in Ophthalmology Conference Abstracts about Trial Outcomes: A Comparison Study (2015) (11)
Female editorship is an important indicator of gender imbalance (2010) (10)
Purchasing oncology services (2000) (10)
Regulatory process effects clinical trial registration in Spain. (1992) (10)
Reference bias in reports of drug trials. (1987) (9)
Controlled trials and meta-analyses can help resolve disagreements among orthopaedic surgeons. (1992) (9)
Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial (2006) (9)
Methods to identify and prioritize patient-centered outcomes for use in comparative effectiveness research (2018) (9)
Evaluation of Clinical Questions and Patient-Important Outcomes Associated With the Treatment of Age-Related Macular Degeneration (2018) (8)
Thomas C Chalmers (1917–1995): a pioneer of randomised clinical trials and systematic reviews (2015) (8)
Learning by doing—teaching systematic review methods in 8 weeks (2014) (8)
Time to Douse the Firestorm Around Breast Cancer Screening (2016) (8)
Participation in the Ischemic Optic Neuropathy Decompression Trial: sex, race, and age. (1997) (8)
Trial registration to prevent duplicate publication. (2004) (8)
Risk factors for publications bias: Results of a follow-up study (1990) (7)
Publication bias in clinical trials (Protocol) (2001) (6)
Missed opportunity from randomised controlled trials of medical interventions for open-angle glaucoma (2017) (6)
Publication of randomized clinical trials in vision research submitted as abstracts to national ophthalmology meetings (1992) (6)
The background review for the USPSTF recommendation on screening for breast cancer. (2010) (6)
3 Problems and limitations in conducting systematic reviews (2001) (6)
Comparative effectiveness research: challenges for medical journals. (2010) (6)
Literature searches (2002) (6)
Evidence-based ophthalmology. (2013) (6)
Comparative effectiveness research: Challenges for medical journals. (2010) (5)
Shaping the future of biomarker research (2007) (5)
Structure and Composition of the Cytoskeleton of Nucleated Erythrocytes (1979) (5)
Trachoma, antibiotics and randomised controlled trials (2006) (5)
Systematic literature review for clinical practice guideline development. (1993) (5)
The Society for Clinical Trials supports United States legislation mandating trials registration (2004) (5)
Report of the What Works Clearinghouse Expert Panel. (2008) (5)
Introduction: The Quality of the Medical Evidence: Is It Good Enough? (1996) (5)
Surgery for nonarteritic anterior ischemic optic neuropathy. (2012) (5)
bias in clinical trials due to statistical significance or direction of trial results ( Review ) (5)
Comparative Effectiveness Research: Challenges for Medical Journals (2010) (4)
Impact of shared scientific or ethical review of multicentre clinical research on the quality of clinical research and the clinical research process (2007) (4)
Surgery for nonarteritic anterior ischemic optic neuropathy. (2015) (4)
Follow-up of trials funded by NIH in 1979: Evidence of publication bias (1991) (4)
Thomas Clark Chalmers (1996) (4)
More on MEDLINE searches. (1988) (4)
Innovation and cross‐fertilization in systematic reviews and meta‐analysis: The influence of women investigators (2015) (4)
Cochrane systematic reviews and co-publication: dissemination of evidence on interventions for ophthalmic conditions (2015) (3)
Increasing, not dictating, choice (2007) (3)
Erratum: Selective exposure reporting and Medline indexing limited the search sensitivity for observational studies of the adverse effects of oral contraceptives (Journal of Clinical Epidemiology (June 2005) 58:6 (560-567)) (2005) (3)
Autumn Books: Look before you quote (1986) (3)
Fisher and Bradford Hill: a discussion (2003) (2)
Development, implementation and evaluation of an online course on evidence-based healthcare for consumers (2020) (2)
Sobre la existencia y los factores de riesgo del sesgo de publicacion (1994) (2)
Comparative Effectiveness Research: Challenges for Medical Journals (2010) (2)
P128 The sensitivity and yield of hand and medline searching for controlled trials in us general medical journals (1997) (2)
Confusion about "negative" studies. (1990) (2)
Publication Bias and the Editorial Process-Reply (1992) (2)
Coding of clinical trials and systematic reviews in The Cochrane Library using international standards. (2007) (2)
Mishandling misconduct: the NSABP lumpectomy trial. National Surgical Adjuvant Breast and Bowel Project. (1994) (2)
Breast screening in women aged 40–49 years (1999) (1)
Results of reviewing MEDLINE records without abstracts (2001) (1)
Purchasing oncology services. Kerr L. White Institute/American Cancer Society Task Force on Purchasing Oncology Services. (2000) (1)
Registering Clinical Trials--Reply (2003) (1)
Literature searches [12] (2002) (1)
Formulation of treatment recommendations for statins. (2014) (1)
Integrating Multiple Data Sources for Meta-analysis to Improve Patient-Centered Outcomes Research (2018) (1)
Francis Bacon to the WHO Recognizing , investigating and dealing with incomplete and biased reporting of clinical research : from (2011) (1)
Surgery for nonarteritic anterior ischemic optic neuropathy. (2006) (1)
Special Theme: Systematic Reviews and Meta-Analysis: (2002) (1)
269-S: Insufficient Reporting and Indexing of Exposures Limit Medline Searches for Observational Studies of Adverse Effects (2005) (1)
Challenges stemming from NIH’s extended registration and reporting requirements (2018) (1)
Assessing the quality of information recorded on trial registries (2005) (1)
The register of randomized controlled trials in perinatal medicine (1985) (1)
The long and creative arm of the drug industry (2005) (1)
LATE-BREAKING ABSTRACT: Birth weight and lung function in later life: A systematic review & meta-analysis (2015) (1)
Visual Fields in the Ischemic Optic Neuropathy Decompression Trial (IONDT): Baseline and Change Over Time (2006) (1)
The current composition of the Cochrane Collaboration's CENTRAL database of controlled trials of healthcare interventions (2001) (1)
Evaluating Hormone Treatments for Women at Increased Risk for Preterm Birth – EPPPIC (2020) (1)
Principios del registro internacional de protocolos y resultados de ensayos clínicos a base de intervenciones de salud en seres humanos: Declaración de Ottawa (parte 1) (2006) (1)
Misunderstandings, misperceptions, and mistakes. (2007) (0)
Evidence Table 37, [All outcomes KQ 1d, impact of CHI applications on clinical outcomes]. (2009) (0)
Points: Sexism and ageism (1988) (0)
05A The international register of RCTS of health care (1995) (0)
Evidence Table 41, [Description of all study designs addressing barriers KQ 2]. (2009) (0)
Table 30, [The distribution of methodology by barrier type.]. (2009) (0)
Finding the Evidence (2008) (0)
Commercial sponsorship of articles (2017) (0)
Evidence Table 35, [Description of RCTs addressing KQ1d (impact of CHI applications on clinical outcomes)]. (2009) (0)
Table 24, [Grade of the body of...]. (2009) (0)
Table 15, [Results of studies on CHI applications impacting intermediate outcomes in asthma and COPD (N=4).]. (2009) (0)
Correction to: Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol (2018) (0)
Comparative effectiveness research: challenges for medical journals. (2010) (0)
Table 11, [Results of studies on CHI applications impacting intermediate outcomes in diabetes (N=6).]. (2009) (0)
Correction to: Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol for a systematic review (2018) (0)
Identification of Systematic Reviews in Vision Research (2007) (0)
Table 28, [Studies of CHI applications impacting economic outcomes (N=3).]. (2009) (0)
Evidence Table 24, [Description of consumer characteristics studies...]. (2009) (0)
Reporting errors: Cochrane reviews expose bias too (2016) (0)
Bias in Editorial Decision Making (2002) (0)
Table 3, [Results of studies of CHI applications impacting intermediate outcomes in breast cancer (N=3).]. (2009) (0)
Evidence Table 42, [Characteristics of consumers in studies addressing barriers to CHI applications]. (2009) (0)
Oncologists’ Confidence in Knowledge of Fertility Issues for Young Women with Cancer (2012) (0)
Evidence Table 26, [Description of RCTs addressing the...]. (2009) (0)
Evidence Table 38, [Description of RCTs addressing the impact of CHI applications on economic outcomes (KQ1e)]. (2009) (0)
Evidence Table 14, [Description of RCTs addressing impact...]. (2009) (0)
Interventions for acute internal hordeolum. (2010) (0)
Grey Literature Detailed Search Strategies (2009) (0)
P129 State-of-the-art in vision randomized controlled clinical trials (1997) (0)
Table 3, Registration and reporting requirements of the U.S. Food and Drug Administration Amendments Act, Section 801a (reprinted with permission from Wood 2009) (2013) (0)
Evidence Table 10, [All outcomes KQ1b, impact of CHI application on intermediate outcomes]. (2009) (0)
Evidence table 4, [Outcomes in studies addressing Key Question 1a, impact of CHI applications on health care processes]. (2009) (0)
301: Rate of Full Publication and Time to Full Publication of Observational Studies (2005) (0)
University of Pennsylvania 10th annual conference on statistical issues in clinical trials: Current issues regarding data and safety monitoring committees in clinical trials (afternoon panel session) (2018) (0)
Table 26, [Grade of the body of evidence addressing CHI impact on clinical outcomes in mental health.]. (2009) (0)
Evidence Table 22, [Outcomes in studies addressing the impact of CHI applications on intermediate outcomes in diabetes]. (2009) (0)
Evidence table 16, [Outcomes in studies addressing the...]. (2009) (0)
Table 27, [Studies of CHI applications impacting miscellaneous clinical outcomes (N=10).]. (2009) (0)
The Importance of Reporting Biases in Patient Care: Can We Trust the Evidence From Either Individual Studies or Systematic Reviews? (2018) (0)
Table 17, [Studies of CHI applications impacting...]. (2009) (0)
Technical Experts and Peer Reviewers (2009) (0)
Challenges stemming from NIH’s extended registration and reporting requirements (2018) (0)
[Table, Detailed Search Strategies]. (2009) (0)
Table 2, Recommended sources of grey literature for conventional drugs and devices (2013) (0)
Evidence Table 34, [Outcomes in studies addressing the impact of CHI applications on relationship-centered outcomes]. (2009) (0)
Standards in the Prevention and Handling of Missing Data for Patient Centered Outcomes Research – A Systematic Review and Expert Consensus (2015) (0)
Evidence table 43, [All barriers identified to the use of CHI applications]. (2009) (0)
Table 22, [Results of studies on CHI applications impacting clinical outcomes in diabetes mellitus (N=3).]. (2009) (0)
[Table, Grey Literature Detailed Search Strategies]. (2009) (0)
Wiley Encyclopedia of Clinical Trials Edited by Ralph B. D'Agostino, Lisa Sullivan, and Joseph Massaro (2009) (0)
Table 9, [Results of studies on CHI applications impacting intermediate outcomes related to obesity (N=11).]. (2009) (0)
Table 14, [Grade of the body of evidence addressing CHI impact on intermediate outcomes in mental health.]. (2009) (0)
P25 Age, sex, and race in ophthalmology randomized clinical trials (1995) (0)
Mishandling Misconduct: The NSABP Lumpectomy Trial (1994) (0)
Table 31, [The distribution of barrier levels by disease/problem domain.]. (2009) (0)
Panel discussion 1 (2012) (0)
REPLY (2007) (0)
Table 4, Percentage of publications from MEDLINE in various languages (1996–2011) (2013) (0)
Evidence Table 40, [All outcomes in studies addressing the impact of CHI applications on economic outcomes (KQ1e)]. (2009) (0)
Evidence Table 33, [Description of consumer characteristics in...]. (2009) (0)
Evidence table 32, [Description of RCTs addressing the impact of CHI applications on relationship-centered outcomes]. (2009) (0)
Interventions for acute internal hordeolum (Review) (2010) (0)
Prevention and treatment of CME after cataract surgery: Author’s reply (1998) (0)
Table 4, [Grade of the body of evidence addressing CHI impact on intermediate outcomes in breast cancer.]. (2009) (0)
Table 1, [Summary of studies of CHI applications impacting health care process outcomes (N=5).]. (2009) (0)
Figure 1, [Conceptual model addressing Key Questions...]. (2009) (0)
Table 1, Types of selective outcome and analysis reporting, which may affect the direction and/or magnitude of the reported study findings (2013) (0)
Author Classification of ARVO Conference Abstracts as Controlled Clinical Trials (2006) (0)
Table 23-B, [Results of studies on CHI...]. (2009) (0)
Table 20, [Results of studies on CHI applications impacting clinical outcomes in breast cancer (N=3)]. (2009) (0)
Evidence Table 8, [Description of RCTs addressing KQ1b (impact of CHI applications on intermediate outcomes)]. (2009) (0)
Evidence Table 2, [Description of RCTs addressing the impact of CHI applications on health care processes (KQ1a)]. (2009) (0)
Table 29, [The distribution of methodologies for...]. (2009) (0)
Evidence table 13, [All outcomes in studies addressing...]. (2009) (0)
Figure 1, Flow diagram of the risk of outcome reporting bias and analysis reporting bias assessment process (2013) (0)
Evidence Table 1, [Jadad criteria for RCT quality]. (2009) (0)
Table 19, [Results of studies on CHI...]. (2009) (0)
The Prevention and Treatment of Missing Data in Clinical Trials. Pannel on Handling Missing Data in Clinical Trials (2010) (0)
Table 12, [Grade of the body of evidence addressing CHI impact on intermediate outcomes in diabetes.]. (2009) (0)
Trial Registration of Randomized Controlled Trials Submitted to ARVO in 2007 (2008) (0)
Table 16, [Grade of the body of evidence addressing CHI impact on intermediate outcomes in asthma/COPD.]. (2009) (0)
[Principles of the international registry of protocols and clinical trial results based on health interventions in human beings: Ottawa Declaration (part 1)]. (2006) (0)
Evidence table 7, [Outcomes in studies addressing KQ1b, impact of CHI application on intermediate outcomes]. (2009) (0)
Table 13, [Results of studies on CHI applications impacting intermediate outcomes of mental health (N=8).]. (2009) (0)
Table 2, [Grade of the body of evidence addressing CHI impact on health care processes in asthma.]. (2009) (0)
Screening for congenital dislocation of the hip (1992) (0)
Table 25, [Results of studies on CHI applications impacting clinical outcomes in mental health (N=7).]. (2009) (0)
Erratum: Shaping the future of biomarker research (Nature Reviews Cancer (2007) 7, (309-315)) (2007) (0)
Editorial effectiveness research: Challenges for medical journals (2010) (0)
Figure 2, [Summary of literature search (number of articles)]. (2009) (0)

This paper list is powered by the following services:

Other Resources About Kay Dickersin

en.wikipedia.org

What Schools Are Affiliated With Kay Dickersin?

Kay Dickersin is affiliated with the following schools: